WDH.F WILLIAM DEMANT HLDG
- Market cap
- EUR 9.53B
- P/E
- 29.4x
- P/B
- 6.90x
- ROE
- 15.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is WDH.F undervalued?
Graham numberThe Graham number of WILLIAM DEMANT HLDG cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
WILLIAM DEMANT HLDG fundamental analysis
No fundamental analysis for WILLIAM DEMANT HLDG yet.
WILLIAM DEMANT HLDG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About WILLIAM DEMANT HLDG
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founde…
Full company profileWILLIAM DEMANT HLDG financial statements
WILLIAM DEMANT HLDG annual financial statements (DKK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 17.9B | 19.7B | 21.6B | 22.4B | 23.0B |
| Gross Profit | 13.5B | 14.7B | 16.3B | 17.1B | 17.4B |
| Operating Income | 3.54B | 3.09B | 4.44B | 4.31B | 3.92B |
| EBITDA | - | 4.29B | 5.57B | 5.80B | 5.17B |
| Net Income | 2.51B | 2.08B | 1.80B | 2.39B | 1.55B |
| EPS | 11 | 9.33 | 8.14 | 11 | 7.33 |
| Balance Sheet | |||||
| Total Assets | 24.9B | 29.9B | 30.5B | 32.5B | 39.1B |
| Total Liabilities | 16.9B | 21.3B | 21.2B | 22.8B | 29.2B |
| Shareholders' Equity | 7.98B | 8.56B | 9.26B | 9.56B | 9.84B |
| Cash & Short-term Investments | 1.17B | 1.13B | 1.14B | 1.11B | 1.33B |
| Cash Flow | |||||
| Operating Cash Flow | 3.59B | 2.62B | 4.46B | 4.08B | 3.85B |
| Capital Expenditure | 726M | 924M | 835M | 779M | 857M |
| Free Cash Flow | 2.87B | 1.70B | 3.62B | 3.30B | 3.00B |
| Ratios | |||||
| ROE | 31.5% | 24.3% | 19.4% | 25.0% | 15.7% |
| ROA | 10.1% | 7.0% | 5.9% | 7.4% | 4.0% |
| Net Profit Margin | 14.0% | 10.6% | 8.3% | 10.6% | 6.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
WILLIAM DEMANT HLDG dividends
WILLIAM DEMANT HLDG has not paid dividends in the last 5 fiscal years.
Last stock split: 5:1 on May 25, 2016.
Who owns WILLIAM DEMANT HLDG
Ownership data of WILLIAM DEMANT HLDG is not available yet.
WILLIAM DEMANT HLDG company profile
- Company name
- WILLIAM DEMANT HLDG
- Ticker
- WDH.F
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 26,616
- Fiscal year end
- December
- Address
- Kongebakken 9, Smørum, Denmark, 2765
- Phone
- 45 39 17 73 00
- Website
- demant.com
About WILLIAM DEMANT HLDG
Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.
WILLIAM DEMANT HLDG management
10- Mr. Søren NielsenCEO, President & Member of Executive Board · born 1970
- Mr. René Schneider M.ScCFO, President of Group Services & Member of Executive Board · born 1973
- Mr. Niels WagnerPresident of Hearing Care & Member of Executive Board · born 1971
- Sara Munch AndersenHead of Group Privacy & Compliance
- Stine BrandenhofGroup General Counsel
- Ms. Trine Kromann-MikkelsenVice President of Corporate Communication and Sustainability
- Mr. Peter PudselykkeHead of Investor Relations (Leave of Absence)
- Ms. Anne-Karen HuntPresident of Diagnostics Business Area · born 1977
- Mr. Bassel RifaiPresident of Hearing Aids Business Area · born 1982
- Gustav Kallehave HoeghInvestor Relations Officer